ÂÜÀòÂÒÂ×

Joerg Ahlgrimm has a diverse work experience in the pharmaceutical industry. Joerg is currently the Chairman of the Board at the Center for Breakthrough Medicines since September 2023 and was previously a Member of the Board of Directors from December 2022 to September 2023. Prior to that, they served as the President and CEO from September 2021 to December 2022 and as the President and COO from September 2020 to September 2021 at the same organization.

In addition, Ahlgrimm has held leadership positions at other notable companies. Joerg was the Chief Executive Officer at SK pharmteco, a trusted partner specializing in the manufacture of APIs and intermediates, from December 2022 onwards. Joerg also served as the Chairman of the Board at Yposkesi, an SK pharmteco company, starting from April 2023.

Before joining SK pharmteco, Ahlgrimm worked at Lonza as the SVP of Global Operations Pharma/Biotech from September 2016 to May 2020. Joerg was also the Head of Global Manufacturing at Baxalta from October 2014 to July 2016. Prior to that, they held various roles at Baxter BioScience, including Vice President Operations, Vice President Global Supply Chain, Director of Supply Chain Management, and Manager of Production Planning / Director of Operations, from 2001 to 2014.

Ahlgrimm's early career includes a role as a Project Manager / Production Planning at Schering AG from September 1997 to March 2001.

Joerg Ahlgrimm obtained a Dipl.-Ing. (FH) degree in Wirtschaftingenieurwesen from Fachhochschule Jena in the years 1993-1997. Joerg also attended the Center of Creative Leadership, though specific details about this experience are not provided.